Capricor Therapeutics, Inc. (CAPR)
30.50
-2.92
(-8.74%)
USD |
NASDAQ |
Mar 13, 16:00
30.45
-0.05
(-0.16%)
After-Hours: 20:00
Capricor Therapeutics EPS Diluted (Quarterly) : -0.6176 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Vaxart, Inc. | 0.2404 |
| Allogene Therapeutics, Inc. | -0.1717 |
| REGENXBIO, Inc. | -1.298 |
| Replimune Group, Inc. | -0.7694 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.17M |
| Total Expenses (Quarterly) | 30.17M |
| Enterprise Value | 1.341B |
| Earnings Yield | -7.40% |
| Normalized Earnings Yield | -7.398 |